Senior Oncology Account Manager - (Birmingham, AL | Remote)
Exelixis
Summary
As a Senior Oncology Account Manager at Exelixis, you will bring deep market knowledge and established relationships within your territory to drive strategic growth. This role is suited for a seasoned oncology sales professional who can independently execute sophisticated account plans, mentor peers, and contribute to cross-functional initiatives. You will refine our approach to compliant engagement with healthcare professionals and serve as a trusted partner to both internal stakeholders and external customers. Your leadership will help shape a high-performance culture grounded in integrity and innovation.
Job description
Essential Duties/Responsibilities
- Drive strategic execution across a complex territory or multi-state geography, delivering sustained commercial impact.
- Expand relationships with healthcare providers and build relations with influential stakeholders to further the knowledge of Exelixis oncology therapies and ensure appropriate use.
- Leverage advanced analytics and market insights to refine territory strategy and influence internal planning.
- Partner cross-functionally to deliver coordinated solutions that address clinical, operational, and access challenges.
- Represent field perspectives in brand planning discussions and contribute to tactical innovation.
- Identify emerging trends, competitive threats, and unmet needs within the territory.
- Model excellence in compliance, professionalism, and ethical engagement.
- Lead strategic pull-through initiatives in collaboration with access and reimbursement teams.
- Serve as a field-based ambassador for new product launches, pilots, and strategic initiatives.
- Cultivate relationships with key opinion leaders, integrated delivery networks, and institutional decision-makers.
- Support regional leadership in business planning, training, and performance calibration.
- Serve as a mentor and resource to junior team members, sharing best practices and supporting skill development.
Supervisory Responsibilities
No direct supervisory responsibilities
Education/Experience/Knowledge & Skills
Education:
- BS/BA degree in related discipline and 9 years of related experience; or
- Master’s degree in related discipline and 7 years of related experience; or
- Equivalent combination of education and experience
Experience:
- Minimum of 5 years of oncology sales experience
- Launch experience required
Knowledge, Skills and Abilities:
- Representative – Relationship Management, Customer Focus, Teamwork, Communication, Influence & Persuasion
- Ability to persuade by presenting complex clinical information
- Strong business planning a requirement
- Ability to work independently
This job requires up to 50% of travel time.
Requirements
- BS/BA degree in related discipline and 9 years of related experience; or Master’s degree in related discipline and 7 years of related experience; or equivalent combination of education and experience
- Minimum of 5 years of oncology sales experience
- Launch experience required
- Relationship Management
- Customer Focus
- Teamwork
- Communication
- Influence & Persuasion
- Ability to persuade by presenting complex clinical information
- Strong business planning
- Ability to work independently
- Ability to travel up to 50% of the time
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Life Insurance
- Disability Insurance
- Flexible Spending Accounts
- Discretionary Annual Bonus
- Sales-based Incentive Plan
- Company Stock Purchase
- Long-term Incentives
- 15 Vacation Days
- 17 Paid Holidays
- Up to 10 Sick Days
Company overview
Exelixis, Inc. is an oncology-focused biotechnology company headquartered in Alameda, California, that specializes in the discovery, development, and commercialization of innovative cancer treatments. Founded in 1994, the company has evolved into a multi-platform cancer organization with a proven track record in the challenging biotech sector. Exelixis is best known for its flagship molecule cabozantinib, an inhibitor of multiple tyrosine kinases including MET, AXL, VEGF receptors, and RET, which has led to several approved drugs for difficult-to-treat cancers. The company's portfolio includes four approved drugs, with two derived from cabozantinib, and it maintains a robust pipeline of next-generation cancer treatments. With approximately 1,500 employees across five continents, Exelixis operates as a publicly traded company (NASDAQ: EXEL) and has established strategic alliances with major pharmaceutical and biotechnology partners. The company's mission centers on transforming science into new treatments that give cancer patients and their families hope for the future, with every employee united in this ambitious cause.